Government Grants
Business Grants
Home Owner Programs
Federal Programs
About Us
Microbiology and Infectious Diseases Research
NO FUNDING WILL BE REPORTED UNDER 93.856.
- Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R01)
- Therapeutic Strategies for the Converging TB/T2DM/HIV Epidemics (R21)
- Assay development and screening for discovery of chemical probes or therapeutic agents (R01)
- Limited Competition: Small Research Grant Program for NIAID K01/K08/K23 Recipients (R03)
- In Vitro and Animal Model Studies on HBV/HIV Co-Infection (R21)
The Department of Health and Human Services is the Federal government's principal agency for protecting the health of all Americans and providing essential human services, especially to those who are least able to help themselves.
PLEASE SEE PROGRAM 93.855; Allergy and Infectious Diseases Research NO FUNDING WILL BE REPORTED UNDER 93.856.
Relevant Nonprofit Program Categories
Selected Recipients for this Program
| Recipient | Amount | Start Date | End Date | |
| University Of Texas Medical Branch At Galveston | $ 1,628,829 | 1997-09-01 | 2026-08-31 | |
| Boston Medical Center Corporation | $ 3,396,993 | 2003-08-01 | 2026-07-31 | |
| University Of Maryland | $ 3,349,877 | 2015-12-01 | 2026-05-31 | |
| Baylor College Of Medicine | $ 1,938,617 | 2003-08-01 | 2025-06-30 | |
| University Of California, Los Angeles | $ 2,411,144 | 2020-08-01 | 2024-03-31 | |
| Duke University | $ 5,618,347 | 2012-04-01 | 2023-04-30 | |
| Trustees Of Columbia University In The City Of New York, The | $ 2,830,956 | 2018-06-08 | 2023-03-31 | |
| University Of California, San Diego | $ 44,503,924 | 1994-04-01 | 2023-03-31 | |
| Leland Stanford Junior University, The | $ 236,550 | 2020-08-05 | 2022-07-31 | |
| Purdue University | $ 3,413,029 | 2017-08-10 | 2022-06-30 |
Program Accomplishments
Not Applicable.
Uses and Use Restrictions
PLEASE SEE PROGRAM 93.855; Allergy and Infectious Diseases Research NO FUNDING WILL BE REPORTED UNDER 93.856.
Eligibility Requirements
Applicant Eligibility
Universities, colleges, hospitals, laboratories and other public or private nonprofit domestic institutions, including State and local units of government.
Individuals are eligible to make application for grant support of research by a named principal investigator or a research career development candidate.
For-profit organizations are also eligible, with the exception of NRSA.
Individual NRSA awardees must be nominated and sponsored by a public or nonprofit private institution having staff and facilities appropriate to the proposed research training program.
All NRSA awardees must be citizens or have been admitted to the United States for permanent residence.
To be eligible, predoctoral candidates must have completed the baccalaureate degree and postdoctoral candidates must have a professional or scientific degree (M.D., Ph.D., D.D.S., D.O., D.V.M., Sc.D., D.Eng.), or must have an equivalent domestic or foreign degree.
SBIR grants can be awarded only to domestic small businesses (entities that are independently owned and operated for profit, are not dominant in the field in which research is being proposed and have no more than 500 employees).
Primary employment (more than one-half time) of the principal investigator must be with the small business at the time of award and during the conduct of the proposed project.
In both Phase I and Phase II, the research must be performed in the U.S.
or its possessions.
To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
STTR grants can be awarded only to domestic small business concerns (entities that are independently owned and operated for profit, are not dominant in the field in which researches proposed and have no more than 500 employees) which 'partner' with a research institution in cooperative research and development.
At least 40 percent of the project is to be performed by the small business concern and at least 30 percent by the research institution.
In both Phase I and Phase II, the research must be performed in the U.S.
and its possessions.
To be eligible for funding, a grant application must be approved for scientific merit and program relevance by a scientific review group and a national advisory council.
Beneficiary Eligibility
Any nonprofit or for-profit organization, company, or institution engaged in biomedical research.
Credentials/Documentation
Research grant applicants must define the objectives, methodology, and facilities for the program, and must present the program director's competence and scientific interest. For SBIR and STTR grants, applicant organization (small business concern) must present in a research plan an idea that has potential for commercialization and furnish evidence that scientific competence, experimental methods, facilities, equipment, and funds requested are appropriate to carry out the plan. Grant forms PHS 6246-1 and PHS 6246-2 are used to apply for SBIR Phase I and Phase II, respectively. Grant forms PHS 6246-3 and PHS 6246-4 are used to apply for STTR Phase I and Phase II, respectively. Applicants for Individual NRSAs must include their academic record, research experience, citizenship, institutional sponsorship, and the proposed area and plan of training in their applications. The applicant for an Institutional NRSA must specify the objectives, methodology, and resources for the research training program, the qualifications and experience of directing staff, the criteria to be used in selecting individuals for award, and a detailed budget and justification for the amount of grant funds requested. For-profit organizations' costs are determined in accordance with Subpart 31.2 of the Federal Acquisition Regulations. For other grantees, costs will be determined by HHS Regulations 45 CFR, Part 74, Subpart Q. 2 CFR 200, Subpart E - Cost Principles applies to this program.
Aplication and Award Process
Preapplication Coordination
Preapplication coordination is not applicable.
Environmental impact information is not required for this program.
This program is excluded from coverage under E.O.
12372.
Application Procedures
This program is excluded from coverage under 2 CFR 200, Uniform Administrative Requirements, Cost Principles, and Audit Requirements for Federal Awards. PLEASE SEE PROGRAM 93.855; Allergy and Infectious Diseases Research NO FUNDING WILL BE REPORTED UNDER 93.856
Award Procedures
PLEASE SEE PROGRAM 93.855; Allergy and Infectious Diseases Research NO FUNDING WILL BE REPORTED UNDER 93.856.
Deadlines
Not Applicable.
Authorization
Small Business Research and Development Enhancement Act of 1992, 42 U.S.C 241; Public Health Service Act, Title IV, Section 301.
Range of Approval/Disapproval Time
PLEASE SEE PROGRAM 93.855; Allergy and Infectious Diseases Research NO FUNDING WILL BE REPORTED UNDER 93.856.
Appeals
A principal investigator may question the substantive or procedural aspects of the review of his/her application by communicating with the staff of the Institute. Final decisions on unresolved appeals are made with the advice of the National Advisory Allergy and Infectious Diseases Council.
Renewals
Renewals of research grant support are by competitive application and review. The competitive application may request support for a segmental period of up to 5 years.
Assistance Considerations
Formula and Matching Requirements
This program has no statutory formula. This program has no matching requirements. This program has MOE requirements, see funding agency for further details.
Length and Time Phasing of Assistance
Research grant project periods average 4 years; these may not be extended beyond 7 years. (Project periods are generally composed of 1-year budget periods.) SBIR: Normally, Phase I awards are for 6 months; normally, Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year; normally, Phase II awards are for 2 years. See the following for information on how assistance is awarded/released: Research grant project periods average 4 years; these may not be extended beyond 7 years. (Project periods are generally composed of 1-year budget periods.) SBIR: Normally, Phase I awards are for 6 months; normally, Phase II awards are for 2 years. STTR: Normally, Phase I awards are for 1 year; normally, Phase II awards are for 2 years.
Post Assistance Requirements
Reports
Yes annual reports requiring progress reports with information on inventions and expenditures are required.
Yes we require quarterly expenditure reports and yearly and/or grant period reports of expenditures.
At the end of the project we expect final expenditure reports.
Yes annual reports requiring progress reports with information on inventions and expenditures are required.
Yes we require quarterly expenditure reports and yearly and/or grant period reports of expenditures.
At the end of the project we expect final expenditure reports.
Yes all yearly and the final progress report are reviewed and monitored.
Audits
In accordance with the provisions of 2 CFR 200, Subpart F - Audit Requirements, non-Federal entities that expend financial assistance of $750,000 or more in Federal awards will have a single or a program-specific audit conducted for that year. Non-Federal entities that expend less than $750,000 a year in Federal awards are exempt from Federal audit requirements for that year, except as noted in 2 CFR 200.503. In addition, grants and cooperative agreements are subject to inspection and audits by DHHS and other Federal government officials. HHS has implemented 2 CFR 200?s administrative requirements, cost principles, and audit requirements under 45 CFR 75.
Records
Expenditures and other financial records must be retained for 3 years from the day on which the grantee submits the last expenditure report for the report period.
Financial Information
Account Identification
75-0885-0-1-552.
Obigations
(Salaries) FY 16 $0; FY 17 est $0; and FY 18 est $0 - PLEASE SEE PROGRAM 93.855; Allergy and Infectious Diseases Research NO FUNDING WILL BE REPORTED UNDER 93.856.
Range and Average of Financial Assistance
PLEASE SEE PROGRAM 93.855; Allergy and Infectious Diseases Research NO FUNDING WILL BE REPORTED UNDER 93.856.
Regulations, Guidelines, and Literature
Not Applicable.
Information Contacts
Regional or Local Office
None. PLEASE SEE PROGRAM 93.855; Allergy and Infectious Diseases Research NO FUNDING WILL BE REPORTED UNDER 93.856.
Headquarters Office
Kevin Richardson 5601 Fishers Lane Suite 5E39, Rockville, Maryland 20852 Email: kevin.richardson@nih.gov Phone: 3017617870
Criteria for Selecting Proposals
See relevant program announcements.
Social Entrepreneurship
Spotlight
Indigital Works to Close the Indigenous and Non-Indigenous Digital Divide
Indigital is Australia’s first Indigenous Edu-tech company, specializing technology development and digital skills training in augmented and mixed realities, artificial intelligence, machine learning, internet of things and geospatial technologies.
